Evidence map›Paper›PMID 23916846›Full record

ArticleGastroenterology2013

The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.

Jens M Werner, Adil Abdalla, Naveen Gara, Marc G Ghany, Barbara Rehermann

Open access · greenAbstract readComparative Study
In one paragraph

Article in Gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Can T Cells Abort SARS-CoV-2 and Other Viral Infections?International journal of molecular sciences · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Occupational exposure and hepatitis B vaccination among health care workers.Revista brasileira de medicina do trabalho : publicacao oficial da Associacao Nacional de Medicina do Trabalho-ANAMT · 2018
    Article
  15. Article
  16. Article
  17. Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Review
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jens M WernerImmunology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
Adil Abdalla
Naveen Gara
Marc G Ghany
Barbara Rehermann
National Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · US

Funding

Immunology of Acute and Chronic Viral Hepatitis in HumansZIADK054509 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI REHERMANN, BARBARA · 2009 to 2025
$15.1M
Intramural NIH HHS ZIA DK054509
6 · The paper itself

Abstract

BACKGROUND &

aimsInfection with hepatitis B virus (HBV) can be prevented by vaccination with HB surface (HBs) antigen, which induces HBs-specific antibodies and T cells. However, the duration of vaccine-induced protective immunity is poorly defined for health care workers who were vaccinated as adults.

methodsWe investigated the immune mechanisms (antibody and T-cell responses) of long-term protection by the HBV vaccine in 90 health care workers with or without occupational exposure to HBV, 10-28 years after vaccination.

resultsFifty-nine of 90 health care workers (65%) had levels of antibodies to HBs antigen above the cut-off (>12 mIU/mL) and 30 of 90 (33%) had HBs-specific T cells that produced interferon-gamma. Titers of antibodies to HBs antigen correlated with numbers of HBs-specific interferon-gamma-producing T cells, but not with time after vaccination. Although occupational exposure to HBV after vaccination did not induce antibodies to the HBV core protein (HBcore), the standard biomarker for HBV infection, CD4(+) and CD8(+) T cells against HBcore and polymerase antigens were detected. Similar numbers of HBcore- and polymerase-specific CD4(+) and CD8(+) T cells were detected in health care workers with occupational exposure to HBV and in patients who acquired immunity via HBV infection. Most of the HBcore- and polymerase-specific T cells were CD45RO(+)CCR7(-)CD127(-) effector memory cells in exposed health care workers and in patients with acquired immunity. In contrast, most of the vaccine-induced HBs-specific T cells were CD45RO(-)CCR7(-)CD127(-) terminally differentiated cells.

conclusionsHBs antigen vaccine-induced immunity protects against future infection but does not provide sterilizing immunity, as evidenced by HBcore- and polymerase-specific CD8(+) T cells in vaccinated health care workers with occupational exposure to HBV. The presence of HBcore- and HBV polymerase-specific T-cell responses is a more sensitive indicator of HBV exposure than detection of HBcore-specific antibodies.

Indexed as

Health PersonnelOccupational ExposureAdultAgedAntibodies, ViralCD8-Positive T-LymphocytesFemaleHepatitis BHepatitis B Surface AntigensHepatitis B VaccinesHepatitis B virusHumansImmunityInfectious Disease Transmission, Professional-to-PatientLongitudinal StudiesMaleAntibodies, ViralHepatitis B Surface AntigensHepatitis B Vaccinesantibody to hepatitis B surface antigenanti-HBsdimethyl sulfoxideDMSOFCSfetal calf serumHBcoreHBsAgHBVHBV core proteinHBVpolHBV polymeraseHDVhepatitis B surface antigenhepatitis B virushepatitis D virusIFNImmune ResponseImmunizationinterferonPBMCPBSPEperipheral blood mononuclear cellsPHA-Mphosphate-buffered salinephycoerythrinphytohemagglutininT CellVirus

Identifiers

PMID23916846
PMCPMC3884684
OpenAlexW2027616974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.